Mi Chen

Mi Chen

Cardiac surgeon
Fuwai Hospital North Building - Beijing, China

Latest contributions

Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention

22 May 2025 – From EuroPCR 2025

Discover innovative non-fluoroscopic interventional techniques with the Percutaneous And Non-fluoroscopic Procedures (PAN) session. Learn how to perform radiation-free interventions using advanced technologies, assess their clinical equivalence to standard methods, and explore how these procedures may promote gender equality in interventional cardiology careers.

Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention

Imaging skills for successful TAVI procedure

21 May 2025 – From EuroPCR 2025

Enhance your imaging skills essential for successful TAVI procedures. This session covers complex scenarios such as left circumflex coronary artery anomalies, valve infolding risks with new platforms, bioprosthesis dysfunctions, procedural adaptations when faced with challenges, and zero-contrast TAVI techniques.

Imaging skills for successful TAVI procedure

Rapid-Fire - TAVI and co-existent coronary artery disease

26 Nov 2024 – From PCR London Valves 2024

Explore a rapid-fire session featuring a selection of compelling clinical cases from PCR London Valves 2024. Discover how interventional cardiologists navigated complex scenarios, including overcoming late radiotherapy consequences, tackling challenging bicuspid aortic stenosis with left main disease, managing TAVI from elective to emergency, performing CTO intervention...

Rapid-Fire - TAVI and co-existent coronary artery disease

Rapid-fire - TAVI-in-SAVR

25 Nov 2024 – From PCR London Valves 2024

Rapid-fire - TAVI-in-SAVR

Mitral valve replacement devices and techniques

16 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on mitral valve replacement devices and techniques. It covers various case presentations and discussions, including the treatment of mitral regurgitation with atrial fixation TMVR, mitral valve-in-valve with a novel device, transcatheter treatment of a structurally degenerated...

Mitral valve replacement devices and techniques

Pushing the limits of transcatheter mitral valve interventions

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions showcasing the latest advancements and challenges in transcatheter mitral valve interventions. Experts will present and discuss complex cases involving severely calcified mitral valves, mitral valve-in-ring implantations, and the management of mitral regurgitation associated with hypertrophic obstructive cardiomyopathy....

Pushing the limits of transcatheter mitral valve interventions

Treating the right valves: not always a straightforward task

15 May 2024 – From EuroPCR 2024

This session focuses on the challenges and complexities involved in the percutaneous treatment of right-sided heart valves, including the tricuspid and pulmonary valves. Attendees will learn from case presentations and discussions on various scenarios, such as recurrent right heart obstructive shock, paravalvular leak closure, and unusual...

Treating the right valves: not always a straightforward task

TAVI - Commissural alignment

20 Nov 2023 – From PCR London Valves 2023

TAVI: novel devices and technologies

18 May 2023 – From EuroPCR 2023

Embark on an exploration of novel devices and technologies in the field of TAVI in this session: learn more about the use of Trilogy JenaValve TAVI in the treatment of critically ill patients with severe aortic regurgitation, uncover the challenges posed by valve infolding induced by...

TAVI: novel devices and technologies

Rapid-fire abstracts: session 1

27 Nov 2022 – From PCR London Valves 2022

Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!

Rapid-fire abstracts: session 1